Accessibility Menu
Perrigo Plc logo

Perrigo Plc(NYSE) PRGO

Market Cap$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1991)+61%
5 Year-59%
1 Year-39%
1 Month+21%
$13.51
+4.16%
+0.54Today
Perrigo Plc last closing stock price
MetricPriceDate
Last closeUSD 12.972026-08-18
Perrigo Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.93%USD 12.852026-08-11
1 month+20.99%USD 10.722026-07-17
3 month+19.24%USD 10.882026-05-20
Year to date-2.26%USD 13.272025-12-31
1 year-38.87%USD 21.222025-08-18
3 year-60.16%USD 32.552023-08-18
5 year-59.49%USD 32.022021-08-19
Since inception+60.77%USD 8.071991-12-17

Perrigo Plc Financials at a Glance

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.14B

Net Income (TTM)

-$1.73B

EPS (TTM)

-$12.51

P/E Ratio

-1.04

Dividend

$1.16

Beta (Volatility)

0.63 (Low)

Price

$13.51

Volume

429,650.538

Open

$13.19

Previous Close

$12.97

Daily Range

$13.19 - $13.60

52-Week Range

$9.23 - $24.61

Estimated Earnings Date

Nov 4, 2026

PRGO News

financial health stethoscope money cash hundred bills medical healthcare-1200x803-37403b6

3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now

Thomas NielApr 29, 2026
financial health stethoscope money cash hundred bills medical healthcare-1200x803-37403b6

3 Healthcare Stocks Paying the Highest Dividends of 2026

Thomas NielFeb 6, 2026
Foolcom-Featured.png

Perrigo (PRGO) Q2 EPS Rises 7.5%

Motley Fool Markets TeamAug 6, 2025
investor considers laptop with notebook

With a Big Catalyst in Hand, Is Perrigo Company a Buy?

Alex CarchidiJul 21, 2023
Birth control pills

FDA Approves Over-the-Counter Birth Control Pill. Is the Pill Maker's Stock Set to Soar?

Keith SpeightsJul 14, 2023
Medical professional with hand on head

Why Perrigo Stock Tanked on Tuesday

Eric VolkmanNov 8, 2022
GettyImages-1271564917

Why Perrigo Stock Bounced Higher Today

Eric VolkmanMar 1, 2022
falling stock chart

Why Perrigo's Stock Is Plunging Today

James BrumleyNov 10, 2021
Page 1

PRGO: Motley Fool Moneyball Superscore

32

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Perrigo Plc

Perrigo Company plc helps people treat common health issues at home. It makes medicine and wellness products sold without a prescription. These products offer affordable health options for families in many countries.

Everyday Health in Every Aisle

  • Self Care Products: Remedies for cough, cold, and digestive issues; includes pain relievers and sleep aids.
  • Specialty Care: Branded solutions for skin health and women's health; includes the Opill contraceptive and ellaOne brands.
  • Infant Formula: Nutritional products designed for infants; includes store brand formula and contract manufacturing services.
  • Oral Care: Daily dental hygiene tools; includes toothbrushes, flossers, and teeth whitening products.

Shifting Gears for Better Results

  • Sold the Dermacosmetics business in April 2026 for $362.9 million to focus on core categories.
  • Completed Project Energize in Dec. 2025 to increase organizational agility and efficiency.
  • Launched an enterprise-wide operational enhancement program in the fourth quarter of 2025 to streamline global operations.
  • Started a strategic review of the infant formula business in Nov. 2025 to assess alternatives for the segment.

A Private Label Powerhouse

Perrigo serves as the primary manufacturer for many store brand health products found in North American retail chains. Its portfolio is highly diversified, with no single product accounting for more than 5% of its total revenue. The company also manages interest rate risk by maintaining fixed rates on more than 90% of its outstanding debt.

A Look at the Books

  • Net sales reached $1.0 billion in the quarter ended June 27, 2026, down 3.2% year over year.
  • Operating income for the six-month period ended June 27, 2026, was a loss of $348.9 million, down 478.0% year over year.
  • The company recorded a pre-tax gain of $129.5 million from the sale of its Dermacosmetics business in the quarter ended June 27, 2026.
  • Market capitalization stood at $1.8 billion with a price-to-earnings (P/E) ratio of 4.6 as of the quarter ended June 27, 2026.

How the Business Is Evolving

Perrigo has transformed into a pure-play consumer self-care business by divesting non-core operations and focusing on branded and store brand wellness solutions.

AI Generated • Aug 6, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

8,100

CEO

Albert A. Manzone, MBA

Website

www.perrigo.com

Headquarters

Dublin, DU D02 TY74, IE

PRGO Financials

Key Financial Metrics (TTM)

Gross Margin

33.26%

Operating Margin

5.19%

Net Income Margin

-41.85%

Return on Equity

-55.97%

Return on Capital

4.97%

Return on Assets

-22.80%

Earnings Yield

-96.15%

Dividend Yield

8.94%

Payout Ratio

-11.52%

Stock Overview

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

138.77M

Volume

429.65K

Avg. Volume

3.41M

Financials (TTM)

Gross Profit

$1.38B

Operating Income

$215.00M

EBITDA

-$1.22B

Operating Cash Flow

$251.80M

Capital Expenditure

-$76.80M

Free Cash Flow

$175.00M

Cash & ST Invst.

$399.70M

Total Debt

$3.29B

Perrigo Plc Performance Analysis

Perrigo Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,450,500,0007.5%
20232023-12-31USD 4,655,100,0004.6%
20242024-12-31USD 4,373,700,000-6.0%
20252025-12-31USD 4,253,200,000-2.8%
Perrigo Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-27-1.2%
Q42025-12-316.4%
Q12026-03-28-12.7%
Q22026-06-275.5%
Perrigo Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.0520.0%
20232023-12-31USD -0.09-91.0%
20242024-12-31USD -1.251231.6%
20252025-12-31USD -10.29723.1%
Perrigo Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-27188.8%
Q42025-12-31-19044.4%
Q12026-03-2871.9%
Q22026-06-27118.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.02B

-3.2%

Gross Profit

$313.90M

-13.5%

Gross Margin

30.69%

N/A

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$222.20K

N/A

Employees

8,100

N/A

Net Income

$74.50M

+986.9%

EBITDA

$143.80M

+11.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$399.70M

-12.0%

Total Debt

$3.29B

-14.0%

Accounts Receivable

$761.20M

+7.7%

Inventory

$1.06B

-12.4%

Long Term Debt

$3.28B

-12.9%

Short Term Debt

$11.40M

-82.5%

Return on Assets

-22.80%

N/A

Return on Invested Capital

3.28%

N/A

Free Cash Flow

$124.00M

+118.7%

Operating Cash Flow

$138.30M

+82.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGRYSurgery Partners, Inc.
$14.06-1.26%
ATECAlphatec Holdings, Inc.
$9.69+1.63%
HCMHUTCHMED (China) Limited
$12.42-1.74%
BHCBausch Health Companies Inc.
$6.78-2.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
MRNAModerna
$141.90+1.25%
IBITiShares Bitcoin Trust
$38.59+0.05%
BITOProShares Trust - ProShares Bitcoin ETF
$9.21+0.05%
INTCIntel
$93.23-0.04%

Questions About PRGO

What is the current price of Perrigo Plc?

Perrigo Plc is trading at $13.51 per share.

What is the 52-week range for Perrigo Plc?

Over the past 52 weeks, Perrigo Plc has traded between $9.23 and $24.61.

How much debt does Perrigo Plc have?

As of the most recent reporting period, Perrigo Plc reported total debt of $3.46B.

How much cash does Perrigo Plc have on hand?

Perrigo Plc reported $399.70M in cash and cash equivalents in its most recent financial results.

What is Perrigo Plc’s dividend yield?

Perrigo Plc currently has a dividend yield of 8.94%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services